Navigation Links
Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimer's Vaccine in 19 Countries
Date:9/19/2007

New Patent Underscores Intellect's Leadership in Immunotherapy for

Alzheimer's Disease

NEW YORK, Sept. 19 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and related disorders, announced today that European Patent No. 1237930 covering chimeric peptide vaccines has been validated in nineteen European countries. The nine month opposition period for the patent expired on August 8, 2007. The patent also has been granted in several other countries outside of Europe. Intellect Neurosciences is the exclusive assignee of the patent, which relates to the Company's RECALL-VAX(TM) technology.

"The validation of our patent in Europe strengthens our competitive advantage in a therapeutic area that is a front runner in the attack against Alzheimer's disease," commented Dr. Daniel Chain, Intellect's Chairman and Chief Executive Officer. "We are excited about this promising technology that possesses a unique combination of safety features, which potentially enables it to be used to treat patients suffering from Alzheimer's disease and also to prevent or delay the onset of this devastating disease."

"There are multiple challenges in developing a means to safely immunize elderly individuals and avoid the failures encountered in previous clinical trials sponsored by major pharmaceutical companies," commented Professor Benjamin Chain, at the Department of Immunology and Molecular Pathology, Windeyer Institute of Medical Sciences, University College London. Professor Chain is the inventor of RECALL-VAX(TM) and is a member of Intellect's Scientific Advisory Board. Professor Chain added: "The major challenges are the need to: mount a robust immune response when the immune system has become senescent as the result of age; avoid autoimmune reactions; and
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Inline intellectual property raises legal issues
2. Intellectual Property: Are you an infringer?
3. Starting a tech business? Step 1 is minding the intellectual property
4. Protect your intellectual property before its too late
5. Protecting your intellectual property in overseas markets
6. Bioanalytical Method Intraday Validation for the Quantitation of Paroxetine in Bovine Plasma using the TSQ Quantum Mass Spectrometer
7. Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A
8. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
9. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
10. Mirus granted European patent for gene therapy
11. Info security group announces first Eastern European chapter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., NEW YORK, Nov. 19 NeoS... it has sent the following letter to its sharehold...ber 30, 2009, of China Biopharmaceuticals Holdings...mpany based in the People,s Republic of China. The...n Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s prim...
(Date:11/19/2009)..., MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeu...patient in a randomized Phase 2B study of AEG35156...velopment for multiple oncology indications. ,,...se 2 Study of the X-Linked Inhibitor of Apoptosis ...h High-dose Cytarabine and Idarubicin in AML Follo...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNewswire... program on one product candidate at an unexpected...te AD02 is planned to enter into,Phase II clinical...,immediately follows the completion of two Phase I...pany based its fast decision on the first interim,...
(Date:11/18/2009)...AIGN, Ill. Imagine a polka-dotted postage stamp t... simply by changing colors. , As reported in the... Kenneth Suslick and his team at the University of...e general detection of toxic industrial chemicals ...orks by visualizing odors. This sensor array coul...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
...looking for an ambitious mission statement, consid...l Finance Adequacy Initiative: "We will not simply...ars, but propose a complete new reuse of all dolla...ol) system, and then any additional dollars if tha...om Still is a member of the initiative] , ,In oth...
... Wis. The Eau Claire Area Economic Development ...rting up again, offering cash awards of up to $10,...nty. , ,For interested entrepreneurs, the EDC is h...en entrants in the Creating Your Own Business Con...ications. , ,Businesses judged to have the best pl...
...now you,ve had a chance to absorb all the news fro...ators, stage presentations here -- click on DEMO... a company). , ,One question that always swirls ar...t want to know what wasn,t at DEMO. The premise of...at hundreds of products and companies and bring on...
Other Biology Technology:Measuring what works and what doesn't in the prototypical school 2Measuring what works and what doesn't in the prototypical school 3Why companies don't get invited to the DEMO conference 2Why companies don't get invited to the DEMO conference 3
(Date:11/19/2009)...g the genetic instructions inside corn, one of the...f the most complex sequences of DNA ever analyzed,...avid Schwartz, who was one of more than 100 author...e maize genome is a true maze full of confusing r...equencers for years," says Schwartz. , Publicati...
(Date:11/19/2009)... maize, also known as corn, researchers across the...uld pave the way to significant improvements in a ... feed and fiber around the world. , The new map,...ap, charts genetic diversity and recombination acr...search team, led by U.S. Department of Agriculture...
(Date:11/19/2009).... Ming Chu Professor of Biochemistry and Molecular... how regulatory proteins control the production of...ing with collaborators including Drs. Mitchell Wei...delphia, they focused specifically on the complex ...). These cells contain large amounts of hemoglobin...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Plants on steroids 3A Key missing link discovered 9829 1Plants on steroids 3A Key missing link discovered 9829 2Rice researchers seek better vaccine procedure 9827 1Rice researchers seek better vaccine procedure 9827 2Rice researchers seek better vaccine procedure 9827 3Children With Asthma More Vulnerable to H1N1 Virus 56460 1Children With Asthma More Vulnerable to H1N1 Virus 56460 2Children With Asthma More Vulnerable to H1N1 Virus 56460 3Children With Asthma More Vulnerable to H1N1 Virus 56460 4
...N, Va., Nov. 18 Stanley, Inc.,(NYSE: SXE ), a l...ional,services to the U.S. federal government, tod...ence Applications International Corporation (NYSE:...task order valued at up to $37.9 million, if,all t...the team will continue,to provide in-service engin...
...BRUNSWICK, N.J. Families gathering around the Tha... side dish that,s been given some "upscale" breedi...he age-old staple will look or taste no different ...elping growers increase production and improve fru...elping them meet the increasing year-round demand ...
...ork, NY, November 18, 2008 -- Researchers at the U...ed that two common cancer drugs have been used to ...F-funded study, published in The Proceedings of t...ey Bluestone, Ph.D., director of the Diabetes Cent...ity. , "The findings suggest that kinase inhibito...
Other Biology News:Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 2Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 3Favorite Thanksgiving dish gets 'upscale' breeding 2
ChemiArray Mouse Lysate Atherosclerosis Antibody Array I, 20 cytokines per membrane from CHEMICON
High-Binding EIA 96 Well Plates from Cayman Chemical
Rabbit Complement from Equitech-Bio
Zymoclean Gel DNA Recovery Kit from Zymo Research
Biology Products: